Synergy Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.31M Sell
5,265
-351
-6% -$359K 0.6% 32
2026
Q1
$5.17M Buy
5,616
+1,414
+34% +$1.43M 0.55% 39
2025
Q4
$4.52M Sell
4,202
-50,043
-92% -$47.9M 0.47% 41
2025
Q3
$42.3M Buy
54,245
+27,380
+102% +$20.4M 1.53% 14
2025
Q2
$20.9M Buy
26,865
+22,758
+554% +$17.7M 2.4% 13
2025
Q1
$3.39M Sell
4,107
-2,904
-41% -$2.42M 0.43% 48
2024
Q4
$5.8M Buy
7,011
+3,799
+118% +$3.15M 0.45% 41
2024
Q3
$2.85M Sell
3,212
-9,980
-76% -$8.97M 0.43% 53
2024
Q2
$11.9M Buy
+13,192
New +$10.6M 1.87% 14

Other funds holding LLY

Synergy Asset Management's LLY Position: Q2 2026 in Review

Synergy Asset Management reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $359K and leaving 5,265 shares worth $6.31M. The position accounts for 0.6% of the portfolio, ranked #32.

Synergy Asset Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $42.3M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Synergy Asset Management held 5,265 shares of Eli Lilly worth $6.31M as of Q2 2026.
  • Synergy Asset Management sold 351 Eli Lilly shares in Q2 2026, an estimated $359K.
  • Eli Lilly made up 0.6% of Synergy Asset Management's portfolio in Q2 2026, its #32 holding.
  • Synergy Asset Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Synergy Asset Management's Eli Lilly position peaked at $42.3M in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Synergy Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.